US Patent 7306796 13-transmembrane protein expressed in prostate cancer

Patent 7306796 was granted and assigned to Agensys on December, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Agensys

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7306796

Date of Patent

December 11, 2007

Patent Application Number

10284660

Date Filed

October 30, 2002

Patent Primary Examiner

‌

Karen A. Canella

Patent abstract

A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7306796 13-transmembrane protein expressed in prostate cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API